Company: CERO
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001213900-25-079898
Chunk: 276

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 2
Chunk 276
---
%
  
    Interest income (expense), net 
     13,776  
     (16,977) 
     30,753  
     181.1%
  
    Total other income (expense), net 
     (693,524) 
     2,699,583  
     (3,393,107) 
     (125.7)%

    Net loss 
     (5,417,315) 
     (2,448,654) 
     (2,968,661) 
     121.2%
  
    Deemed dividend on Series A, Series B and C Preferred Stock 
     (24,700,374) 
     -  
     (24,700,374) 
     100.0%
  
    Net loss attributable to common stockholders 
    $(30,117,689) 
    $(2,448,654) 
    $(27,669,035) 
     1,130.0%

Research
and Development Expenses

Research and development expenses were $2,754,000 for the three months
ended June 30, 2025 as compared to $2,714,000 for the three months ended June 30, 2024, reflecting an increase of $40,000. The increase
was primarily attributable to an increase in clinical expenses of approximately $1,056,000 and an increase in scientific consulting fees
of $93,000, offset by a decrease in salaries and benefits of $893,000 primarily due to a decrease in stock-based compensation of $728,000
attributable to a decrease in accretion of stock option expense, and a decrease in lab and other expenses of $216,000. During the first
quarter of 2025, we began clinical trials related to the IND for CER-1236.

The
Company anticipates that its R&D expenses will significantly increase in the future as the Company increases headcount, compensation
expense, and contracted services for preclinical and clinical development of its product candidates, as well as for manufacturing of
clinical product to be used in clinical development.

General
and Administrative Expenses

General and administrative expenses were $1,970,000 for the three months
ended June 30, 2025 as compared to $2,434,000 for the three months ended June 30, 2024, reflecting a decrease of approximately $464,000.
The decrease